294 related articles for article (PubMed ID: 27615271)
1. Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related.
Falasca K; Reale M; Ucciferri C; Di Nicola M; Di Martino G; D'Angelo C; Coladonato S; Vecchiet J
AIDS Res Hum Retroviruses; 2017 Mar; 33(3):246-253. PubMed ID: 27615271
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda.
Rubin LH; Saylor D; Nakigozi G; Nakasujja N; Robertson K; Kisakye A; Batte J; Mayanja R; Anok A; Lofgren SM; Boulware DR; Dastgheyb R; Reynolds SJ; Quinn TC; Gray RH; Wawer MJ; Sacktor N
J Neurovirol; 2019 Dec; 25(6):800-813. PubMed ID: 31218522
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.
Abassi M; Morawski BM; Nakigozi G; Nakasujja N; Kong X; Meya DB; Robertson K; Gray R; Wawer MJ; Sacktor N; Boulware DR
J Neurovirol; 2017 Jun; 23(3):369-375. PubMed ID: 27995575
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
[TBL] [Abstract][Full Text] [Related]
5. A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen.
Muñoz-Moreno JA; Prats A; Pérez-Álvarez N; Fumaz CR; Garolera M; Doval E; Negredo E; Ferrer MJ; Clotet B;
J Acquir Immune Defic Syndr; 2013 Aug; 63(5):585-92. PubMed ID: 24135776
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals.
Suh HS; Lo Y; Choi N; Letendre S; Lee SC
J Neuroinflammation; 2015 Apr; 12():72. PubMed ID: 25890304
[TBL] [Abstract][Full Text] [Related]
7. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.
Su T; Schouten J; Geurtsen GJ; Wit FW; Stolte IG; Prins M; Portegies P; Caan MW; Reiss P; Majoie CB; Schmand BA;
AIDS; 2015 Mar; 29(5):547-57. PubMed ID: 25587908
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis after antiretroviral therapy in a longitudinal cohort of sexually infected HIV patients in eastern China.
Wei Q; Lin H; Ding Y; Liu X; Wu Q; Shen W; Gao M; He N
Biosci Trends; 2017 Jul; 11(3):274-281. PubMed ID: 28484111
[TBL] [Abstract][Full Text] [Related]
9. Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
Vassallo M; Durant J; Biscay V; Lebrun-Frenay C; Dunais B; Laffon M; Harvey-Langton A; Cottalorda J; Ticchioni M; Carsenti H; Pradier C; Dellamonica P
AIDS; 2014 Feb; 28(4):493-501. PubMed ID: 24472743
[TBL] [Abstract][Full Text] [Related]
10. Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals.
Ceccarelli G; Brenchley JM; Cavallari EN; Scheri GC; Fratino M; Pinacchio C; Schietroma I; Fard SN; Scagnolari C; Mezzaroma I; Vullo V; d'Ettorre G
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29160817
[TBL] [Abstract][Full Text] [Related]
11. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort.
Moore DJ; Roediger MJ; Eberly LE; Blackstone K; Hale B; Weintrob A; Ganesan A; Agan BK; Letendre SL; Crum-Cianflone NF
PLoS One; 2012; 7(11):e47310. PubMed ID: 23144815
[TBL] [Abstract][Full Text] [Related]
12. Effect of non-nucleoside reverse transcriptase inhibitors on cytokine, chemokine, and immunoglobulin profiles in serum and genital secretions of HIV-infected women.
Sachdeva RK; Wanchu A; Bagga R; Malla N; Sharma M
J Interferon Cytokine Res; 2010 May; 30(5):299-310. PubMed ID: 20187769
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive profile of HIV-positive adults on combined antiretroviral therapy: A single-centre study in Serbia.
Malagurski B; Bugarski Ignjatović V; Marić D; Nikolašević Ž; Mihić L; Brkić S
Appl Neuropsychol Adult; 2018; 25(6):513-522. PubMed ID: 28665215
[TBL] [Abstract][Full Text] [Related]
14. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
[TBL] [Abstract][Full Text] [Related]
15. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
[TBL] [Abstract][Full Text] [Related]
16. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
[TBL] [Abstract][Full Text] [Related]
17. Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals.
Kalayjian RC; Robertson KR; Albert JM; Fichtenbaum CJ; Brown TT; Taiwo BO;
J Acquir Immune Defic Syndr; 2019 Jun; 81(2):e49-e54. PubMed ID: 30939531
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive performance and quality of life in patients with HIV infection.
Tozzi V; Balestra P; Galgani S; Murri R; Bellagamba R; Narciso P; Antinori A; Giulianelli M; Tosi G; Costa M; Sampaolesi A; Fantoni M; Noto P; Ippolito G; Wu AW
AIDS Res Hum Retroviruses; 2003 Aug; 19(8):643-52. PubMed ID: 13678465
[TBL] [Abstract][Full Text] [Related]
19. Empiric neurocognitive performance profile discovery and interpretation in HIV infection.
Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E
J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal neuropsychological test performance among HIV seropositive individuals in Uganda.
Sacktor N; Nakasujja N; Okonkwo O; Skolasky RL; Robertson K; Musisi S; Katabira E
J Neurovirol; 2013 Feb; 19(1):48-56. PubMed ID: 23315423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
